Human Mixed Lineage Kinase Domain Like Protein (MLKL) ELISA Kit

Necroptosis research requires reliable quantification of MLKL (Mixed Lineage Kinase Domain Like Protein), the pseudokinase that executes this caspase-independent programmed cell death pathway. Supplied by Assay Genie, this ELISA kit enables quantitative measurement of human MLKL in research samples, supporting studies of the RIPK1/RIPK3 signaling cascade that culminates in MLKL phosphorylation, oligomerization, and translocation to the plasma membrane.

The assay accommodates cell lysates and tissue homogenates from experimental systems modeling necroptotic cell death. Investigations into inflammatory diseases, ischemia-reperfusion injury, acute kidney injury, and tumor biology benefit from monitoring MLKL abundance, particularly when comparing wild-type and knockout phenotypes or evaluating pharmacological inhibitors of upstream kinases. Researchers using necroptosis inducers such as TNF-alpha, SM-164, and caspase inhibitors like z-VAD-fmk can correlate MLKL protein levels with downstream membrane permeabilization events.

Each kit includes pre-coated microwells, protein standards packaged in vials, detection reagents, substrate, stop solution, and wash buffer for completing the protocol. Reconstituted standards should be aliquoted and stored at -20 degrees C to preserve activity through repeated freeze-thaw cycles, while unused microwells remain stable refrigerated in their sealed pouch with desiccant. The assay produces a measurable signal proportional to MLKL concentration in the sample. For research use only; not intended for diagnostic applications.